Baird Financial Group’s OncoMed Pharmaceuticals, Inc. OMED Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Sell |
-12,000
| Closed | -$12K | – | 1577 |
|
|
2019
Q1 | $12K | Hold |
12,000
| – | – | ﹤0.01% | 1282 |
|
|
2018
Q4 | $9K | Hold |
12,000
| – | – | ﹤0.01% | 1263 |
|
|
2018
Q3 | $25K | Hold |
12,000
| – | – | ﹤0.01% | 1323 |
|
|
2018
Q2 | $28K | Hold |
12,000
| – | – | ﹤0.01% | 1275 |
|
|
2018
Q1 | $38K | Hold |
12,000
| – | – | ﹤0.01% | 1242 |
|
|
2017
Q4 | $49K | Hold |
12,000
| – | – | ﹤0.01% | 1253 |
|
|
2017
Q3 | $54K | Hold |
12,000
| – | – | ﹤0.01% | 1224 |
|
|
2017
Q2 | $40K | Hold |
12,000
| – | – | ﹤0.01% | 1218 |
|
|
2017
Q1 | $111K | Hold |
12,000
| – | – | ﹤0.01% | 1197 |
|
|
2016
Q4 | $93K | Buy |
+12,000
| New | +$93K | ﹤0.01% | 1175 |
|